The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus
Abstract
BACKGROUND: Epidemiological and basic science evidence suggests that magnesium sulphate before birth may be neuroprotective for the fetus. OBJECTIVES: To assess the effects of magnesium sulphate as a neuroprotective agent when given to women considered at risk of preterm birth. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 August 2008). SELECTION CRITERIA: Randomised controlled trials of antenatal magnesium sulphate therapy in women threatening or likely to give birth at less than 37 weeks' gestational age. For one subgroup analysis, studies were broadly categorised by the primary intent of the study into "neuroprotective intent", or "other intent (maternal neuroprotective - pre-eclampsia)", or "other intent (tocolytic)". DATA COLLECTION AND ANALYSIS: At least two authors assessed trial eligibility and quality, and extracted data. MAIN RESULTS: Five trials (6145 babies) were eligible for this review. Antenatal magnesium sulphate therapy given to women at risk of preterm birth substantially reduced the risk of cerebral palsy in their child (Relative Risk (RR) 0.68; 95% Confidence interval (CI) 0.54 to 0.87; five trials; 6145 infants). There was also a significant reduction in the rate of substantial gross motor dysfunction (RR 0.61; 95% CI 0.44 to 0.85; four trials; 5980 infants). No statistically significant effect of antenatal magnesium sulphate therapy was detected on paediatric mortality (RR 1.04; 95% CI 0.92 to 1.17; five trials; 6145 infants), or on other neurological impairments or disabilities in the first few years of life. Overall there were no significant effects of antenatal magnesium therapy on combined rates of mortality with cerebral palsy, although there were significant reductions for the neuroprotective groups RR 0.85; 95% CI 0.74 to 0.98; four trials; 4446 infants, but not for the other intent subgroups. There were higher rates of minor maternal side effects in the magnesium groups, but no significant effects on major maternal complications. AUTHORS' CONCLUSIONS: The neuroprotective role for antenatal magnesium sulphate therapy given to women at risk of preterm birth for the preterm fetus is now established. The number of women needed to be treated to benefit one baby by avoiding cerebral palsy is 63 (95% confidence interval 43 to 87). Given the beneficial effects of magnesium sulphate on substantial gross motor function in early childhood, outcomes later in childhood should be evaluated to determine the presence or absence of later potentially important neurological effects, particularly on motor or cognitive function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Palisano, R., Rosenbaum, P., Walter, S., Russell, D., Wood, E., & Galuppi, B. (1997) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1997.tb07414.x · Cited by 6,721
Bayley Scales of Infant Development
(2007) · Encyclopedia of Measurement and Statistics · doi:10.4135/9781412952644.n48 · Cited by 4,240
Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers
Cans, C. (2000) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2000.tb00695.x · Cited by 1,635
Births: preliminary data for 2012.
Hamilton, B. E., Martin, J. A., & Ventura, S. J. (2013) · PubMed · Cited by 1,509
Bayley Scales of Infant Development
Lennon, E. M., Gardner, J. M., Karmel, B. Z., & Flory, M. J. (2020) · Encyclopedia of Infant and Early Childhood Development · doi:10.1016/b978-0-12-809324-5.23376-2 · Cited by 1,310
Diagnosis and Management of Gestational Hypertension and Preeclampsia
Sibai, B. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(03)00475-7 · Cited by 1,146
Hagberg, B., Hagberg, G., Olow, I., & Wendt, L. V. (1996) · Acta Paediatrica · doi:10.1111/j.1651-2227.1996.tb14193.x · Cited by 917
Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers
(SCPE), S. O. C. P. I. E. (2001) · Developmental Medicine and Child Neurology · doi:10.1017/s0012162200001511 · Cited by 908
A Randomized, Controlled Trial of Magnesium Sulfate for the Prevention of Cerebral Palsy
Rouse, D. J., Hirtz, D. G., Thom, E., Varner, M. W., Spong, C. Y., Mercer, B. M., Iams, J. D., Wapner, R. J., Sorokin, Y., Alexander, J. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801187 · Cited by 708
Self-citationMartin, J. A., Hamilton, B. E., Sutton, P. D., Ventura, S. J., Menacker, F., Kirmeyer, S., & Munson, M. L. (2007) · PubMed · Cited by 637
Crowther, C. A. (2003) · JAMA · doi:10.1001/jama.290.20.2669 · Cited by 624
Self-citationMagnesium sulphate and other anticonvulsants for women with pre-eclampsia
Duley, L., Gülmezoglu, A. M., Henderson-Smart, D. J., & Chou, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000025.pub2 · Cited by 586
Stewart, L. A., & Tierney, J. F. (2002) · Evaluation & the Health Professions · doi:10.1177/0163278702025001006 · Cited by 571
The Changing Panorama of Cerebral Palsy in Sweden: IV. Epidemiological Trends 1959–78
HAGBERG, B., HAGBERG, G., & OLOW, I. (1984) · Acta Paediatrica · doi:10.1111/j.1651-2227.1984.tb09951.x · Cited by 520
Hagberg, B., Hagberg, G., Beckung, E., & Uvebrant, P. (2001) · Acta Paediatrica · doi:10.1080/080352501300067532 · Cited by 506
Trends in the Prevalence of Cerebral Palsy in a Population-Based Study
Winter, S., Autry, A., Boyle, C., & Yeargin-Allsopp, M. (2002) · Pediatrics · doi:10.1542/peds.110.6.1220 · Cited by 435
Twins, triplets, and cerebral palsy in births in Western Australia in the 1980s.
Petterson, B., Nelson, K. B., Watson, L., & Stanley, F. (1993) · BMJ · doi:10.1136/bmj.307.6914.1239 · Cited by 427
HIMMELMANN, K., HAGBERG, G., BECKUNG, E., HAGBERG, B., & UVEBRANT, P. (2005) · Acta Paediatrica · doi:10.1111/j.1651-2227.2005.tb03071.x · Cited by 367
A Quantitative Review of Mortality and Developmental Disability in Extremely Premature Newborns
Lorenz, J. M., Wooliever, D. E., Jetton, J. R., & Paneth, N. (1998) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.152.5.425 · Cited by 320
Magnesium sulphate for preventing preterm birth in threatened preterm labour
Crowther, C. A., Brown, J., McKinlay, C. J., & Middleton, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001060.pub2 · Cited by 317
Self-citationMagnesium sulphate versus diazepam for eclampsia
Duley, L., Henderson-Smart, D. J., Walker, G. J., & Chou, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000127.pub2 · Cited by 307
Marret, S., Marpeau, L., Zupan-Simunek, V., Eurin, D., Lévêque, C., Hellot, M.-F., Bénichou, J., & PREMAG trial group (2006) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01162.x · Cited by 275
Self-citationMittendorf, R., Dambrosia, J., Pryde, P. G., Lee, K.-S., Gianopoulos, J. G., Besinger, R. E., & Tomich, P. G. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.123544 · Cited by 265
Magnesium supplementation in pregnancy
Makrides, M., Crosby, D. D., Shepherd, E., & Crowther, C. A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000937.pub2 · Cited by 263
Self-citationMagnesium sulphate versus phenytoin for eclampsia
Duley, L., Henderson-Smart, D. J., & Chou, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000128.pub2 · Cited by 246
Trends in perinatal mortality and cerebral palsy in Western Australia, 1967 to 1985.
Stanley, F. J., & Watson, L. (1992) · BMJ · doi:10.1136/bmj.304.6843.1658 · Cited by 238
Outcome at 5 Years of Age of Children 23 to 27 Weeks' Gestation: Refining the Prognosis
Doyle, L. W., & for the Victorian Infant Collaborative Study Group (2001) · Pediatrics · doi:10.1542/peds.108.1.134 · Cited by 237
Self-citationSchendel, D. E. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540220029026 · Cited by 236
Is tocolytic magnesium sulphate associated with increased total paediatric mortality?
Mittendorf, R., Covert, R., Boinan, J., Khoshnood, B., Lee, K.-S., & Siegler, M. (1997) · The Lancet · doi:10.1016/s0140-6736(97)24047-x · Cited by 219
Magnesium sulphate and other anticonvulsants for women with pre-eclampsia
Duley, L., Gülmezoglu, A. M., & Henderson-Smart, D. J. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000025 · Cited by 210
Epidemiology of cerebral palsy in England and Scotland, 1984–9
Pharoah, P. O. D., Cooke, T., Johnson, M. A., King, R., & Mutch, L. (1998) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.79.1.f21 · Cited by 197
Magnesium sulphate for preventing preterm birth in threatened preterm labour
Crowther, C. A., Hiller, J. E., & Doyle, L. W. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001060 · Cited by 195
Self-citationMagnesium sulphate versus diazepam for eclampsia
Duley, L., & Henderson-Smart, D. J. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000127 · Cited by 171
Magpie Trial Follow‐Up Study Collaborative Group (2007) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01165.x · Cited by 168
Magnesium sulphate versus lytic cocktail for eclampsia
Duley, L., Gülmezoglu, A. M., & Chou, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002960.pub2 · Cited by 167
Intrauterine infection and the risk of cerebral palsy in very low-birthweight infants
O’Shea, Klinepeter, Meis, & Dillard (1998) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.1998.00081.x · Cited by 138
Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia.
Levene, M. I., Blennow, M., Whitelaw, A., Hanko, E., Fellman, V., & Hartley, R. (1995) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.73.3.f174 · Cited by 110
Outcome at 2 years of children 23–27 weeks' gestation born in Victoria in 1991–92
THE VICTORIAN INFANT COLLABORATIVE STUDY GROUP (1997) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1997.tb01021.x · Cited by 106
Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour
Han, S., Crowther, C. A., & Moore, V. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000940.pub3 · Cited by 100
Self-citationMagnesium sulphate versus lytic cocktail for eclampsia
Duley, L., & Gülmezoglu, A. M. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002960 · Cited by 99
Marret, S., Marpeau, L., Follet-Bouhamed, C., Cambonie, G., Astruc, D., Delaporte, B., Bruel, H., Guillois, B., Pinquier, D., Zupan-Simunek, V., et al. (2008) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2008.01.012 · Cited by 90
Self-citationMagnesium supplementation in pregnancy
Makrides, M., & Crowther, C. A. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000937 · Cited by 87
Self-citationMagnesium sulphate versus phenytoin for eclampsia
Duley, L., & Henderson-Smart, D. J. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000128 · Cited by 86
Analysis by gestational age of cerebral palsy in singleton births in north‐east England 1970–94
Drummond, P. M. D. C., & Colver, A. F. (2002) · Paediatric and Perinatal Epidemiology · doi:10.1046/j.1365-3016.2002.00408.x · Cited by 71
Weintraub, Z., Solovechick, M., Reichman, B., Rotschild, A., Waisman, D., Davkin, O., Lusky, A., & Bental, Y. (2001) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.85.1.f13 · Cited by 65
Cerebral palsy rates among low-birthweight infants fell in the 1990s
Surman, G., Newdick, H., & Johnson, A. (2003) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162203000859 · Cited by 61
Perinatal risk factors for adverse neurodevelopmental outcome after spontaneous preterm birth
Vermeulen, G. M., Bruinse, H. W., & de Vries, L. S. (2001) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(01)00383-9 · Cited by 54
Blasco, P. A. (1994) · Clinical Pediatrics · doi:10.1177/000992289403300703 · Cited by 43
Cited by
European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2019 Update
Sweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., Simeoni, U., et al. (2019) · Neonatology · doi:10.1159/000499361 · Cited by 1,613
Mol, B. W. J., Roberts, C. T., Thangaratinam, S., Magee, L. A., de Groot, C. J. M., & Hofmeyr, G. J. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00070-7 · Cited by 1,597
European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update
Sweet, D. G., Carnielli, V. P., Greisen, G., Hallman, M., Klebermass-Schrehof, K., Ozek, E., te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., et al. (2023) · Neonatology · doi:10.1159/000528914 · Cited by 704
Magnesium sulphate and other anticonvulsants for women with pre-eclampsia
Duley, L., Gülmezoglu, A. M., Henderson-Smart, D. J., & Chou, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000025.pub2 · Cited by 586
Colver, A., Fairhurst, C., & Pharoah, P. O. D. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61835-8 · Cited by 577
Metadata
- Authors
- Doyle, L. W., Crowther, C. A., Middleton, P., Marret, S., & Rouse, D.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2009-01-21
- Issue
- 1
- Pages
- CD004661-CD004661
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1708013175
- Cited by
- 807
- References
- 50
- FWCI
- 36.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.